Steris | STE - Ebitda


Steris reported $394.7M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
3M USD 1.42B 8M Mar/2026
Accuray USD -685K 900K Sep/2024
Avanos Medical USD 13M 3M Dec/2025
Baxter International USD -447M 873M Dec/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.16B 213M Dec/2025
CONMED USD 56.39M 23.97M Mar/2026
Cooper Companies USD 323.4M 13.2M Dec/2025
Dexcom USD 364.5M 57.7M Mar/2026
Ecolab USD 1.04B 8.5M Dec/2025
Edwards Lifesciences USD 70.1M 394.2M Dec/2025
Fortive USD 314M 25.3M Mar/2026
Getinge SEK 3.47B 2.13B Dec/2024
Globus Medical USD 280.46M 27.86M Dec/2025
Haemonetics USD 94.78M 20.75M Dec/2025
Idexx Laboratories USD 400.87M 45.95M Mar/2026
Insulet USD 181.7M 12.3M Mar/2026
Integra LifeSciences USD 76.18M 28.03M Mar/2026
Intuitive Surgical USD 1.09B 165.5M Dec/2025
J&J USD 7.19B 2.32B Dec/2025
Masimo USD 85.5M 6.4M Mar/2026
Olympus JPY 43.41B 2.31B Mar/2026
Orthofix International USD 27.88M 2.77M Dec/2025
Owens Minor USD 90.02M 2.15M Dec/2025
ResMed USD 547.48M 27.46M Dec/2025
Steris USD 394.7M 5M Dec/2025
Stryker USD 1.57B 618M Mar/2026
Tandem Diabetes Care USD 2.73M 30.17M Mar/2026
Teleflex USD 247.07M 575.88M Dec/2025
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025